Subtypes in #cholangiocarcinoma: anatomy is only scratching the surface https://t.co/1gDNOkxuRG
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jun 2022 – Feb 2025Where it's discussed
-
X / Twitter106 posts
-
News2 articles
-
YouTube1 videos
AI synopsis
What people are saying
Several discussions highlight critical points from the article, such as the identification of actionable alterations in over 30% of biliary tract cancer cases and the varying immune microenvironments across subtypes. Comments like 'genomic subtype needs more consideration' and 'this research can inform future combination treatment strategies' demonstrate the thoughtful analysis and enthusiastic tone of the contributors, conveying excitement about the potential advancements in treatment approaches.
The majority of posts express strong agreement with the findings of the publication, indicating a consensus on its validity.
There is a high level of interest evident from the posts, with many users actively discussing the implications of the research.
Many contributing to the discussions delve into specific methodologies and clinical implications, reflecting deep engagement with the content.
The publication is perceived as having a significant impact on the field, as many posts highlight its potential to influence treatment approaches.
Abstract in brief
- Biliary tract cancers (BTCs) have a poor prognosis, and understanding their immune landscape could enhance patient selection for immunotherapy and guide combination treatments.
- Analysis of 454 BTC samples revealed varying mutational frequencies across subtypes, with significant actionable alterations found in 30.5% of cases.
- Four distinct molecular clusters were identified, indicating that specific genetic changes in BTCs correlate with different immune microenvironments, potentially informing new treatments.
Top posts
Most liked on X and BlueskyClinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures | JCO Precision Oncology @fedenichetti @StefanFrohling https://t.co/Dn3Pt9bH87
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine https://t.co/UirQNm1EBZ
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine https://t.co/IosbVwtMPj
This study was funded by the Mark R. Clements Award. It analyzed deidentified clinical, genomic, & transcriptomic data from the Tempus database to determine the mutational frequency & mutational clustering across the 3 BTC subtypes. https://t.co/YGbXOtD8tT #cholangiocarcinoma
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsKNI7d #hpbcsm #PrecisionMedicine https://t.co/YoYVqbA5Ph
All mentions
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Spec...
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine https://t.co/5CRF3v3mBQ
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine https://t.co/gDmdauoVpP
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5Rll #hpbcsm #PrecisionMedicine https://t.co/nytle4h9xI
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine https://t.co/wGGCJjREB4
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine https://t.co/gBxBzkp8Qf
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine https://t.co/UirQNm1EBZ
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine https://t.co/IosbVwtMPj
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine https://t.co/kRF0imgF4q
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine https://t.co/oRpZTyWjU0
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine https://t.co/8jf8J6mU0k
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5Rll #hpbcsm #PrecisionMedicine https://t.co/g9ORLHVkoi
#TwuesdayTweetss Today in #TwuesdayTweetss we feature, Mark Yarchoan [@MarkYarchoan] regarding his tweet about Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer which reveals subtype-specific Immune Signatures.
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine https://t.co/mDRPIMn0s2
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine https://t.co/0nXoJA4GJu
RT @FogacciJoao: @RachelRiechelm2 @MPishvaian @AJacomeMD @KellyBorgesAra2 @GIcancerDoc @rachnatshroff @JavleMilind @DocCatenacci @GABOUALFA…
@RachelRiechelm2 @MPishvaian @AJacomeMD @KellyBorgesAra2 @GIcancerDoc @rachnatshroff @JavleMilind @DocCatenacci @GABOUALFA @RenataDAlpino @duiliorocha_onc @EileenMOReilly @jaypsv @BenWestphalen @MiteshBorad Small numbers❗️ ➡️ So much yet to know. These data show GB as the most inflamed tumor immune microenvironment
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5Rll #hpbcsm #PrecisionMedicine
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5Rll #hpbcsm #PrecisionMedicine https://t.co/jnB5udBc8z
RT @BenWestphalen: Very interesting @ASCO @JCOPO_ASCO #Podcast on #PrecisionOncology in biliary tract #Cancer with @MarkYarchoan
RT @BenWestphalen: Very interesting @ASCO @JCOPO_ASCO #Podcast on #PrecisionOncology in biliary tract #Cancer with @MarkYarchoan
RT @BenWestphalen: Very interesting @ASCO @JCOPO_ASCO #Podcast on #PrecisionOncology in biliary tract #Cancer with @MarkYarchoan
Very interesting @ASCO @JCOPO_ASCO #Podcast on #PrecisionOncology in biliary tract #Cancer with @MarkYarchoan
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5Rll #hpbcsm #PrecisionMedicine
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5Rll #hpbcsm #PrecisionMedicine https://t.co/g5ErNLvmQ2
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsKNI7d #hpbcsm #PrecisionMedicine https://t.co/jb5iz2QxE2
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5Rll #hpbcsm #PrecisionMedicine https://t.co/WwJfaYpKbk
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5Rll #hpbcsm #PrecisionMedicine
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures | JCO Precision Oncology @fedenichetti @StefanFrohling https://t.co/Dn3Pt9bH87
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine https://t.co/Xm6rT0uszl
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine https://t.co/k1PEhYKaqZ
RT @JCOPO_ASCO:
RT @JCOPO_ASCO:
RT @JCOPO_ASCO:
RT @curecc: This study was funded by the Mark R. Clements Award. It analyzed deidentified clinical, genomic, & transcriptomic data from the…
RT @curecc: This study was funded by the Mark R. Clements Award. It analyzed deidentified clinical, genomic, & transcriptomic data from the…
RT @curecc: This study was funded by the Mark R. Clements Award. It analyzed deidentified clinical, genomic, & transcriptomic data from the…
RT @curecc: This study was funded by the Mark R. Clements Award. It analyzed deidentified clinical, genomic, & transcriptomic data from the…
RT @curecc: This study was funded by the Mark R. Clements Award. It analyzed deidentified clinical, genomic, & transcriptomic data from the…
RT @curecc: This study was funded by the Mark R. Clements Award. It analyzed deidentified clinical, genomic, & transcriptomic data from the…
This study was funded by the Mark R. Clements Award. It analyzed deidentified clinical, genomic, & transcriptomic data from the Tempus database to determine the mutational frequency & mutational clustering across the 3 BTC subtypes. https://t.co/YGbXOtD8tT #cholangiocarcinoma
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsKNI7d #hpbcsm #PrecisionMedicine https://t.co/BQUa2IMRUY
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine https://t.co/hd9jrQMxDa
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsKNI7d #hpbcsm #PrecisionMedicine https://t.co/WSeNecSK95
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
RT @kmody29: @GillSharlene @ESMOWorldGI I would argue that we need to start considering genomic subtype in addition to/ instead of anatomic…
RT @kmody29: @GillSharlene @ESMOWorldGI I would argue that we need to start considering genomic subtype in addition to/ instead of anatomic…
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine https://t.co/lig3AbAwva
@GillSharlene @ESMOWorldGI I would argue that we need to start considering genomic subtype in addition to/ instead of anatomical subtype. Genomic subtypes assoc with/?drive immune micro environment differences. See: https://t.co/ime5u4jPr8 @MarkYarchoan @TempusLabs
.@MarkYarchoan et al. with genomic & transcriptomic data from >450 #Cholangiocarcinoma pts identify actionable alterations in >30% w/ molecularly defined clusters having unique immunophenotypes. Potentially informing future combination IO strategies?
RT @angelopirozzi3: Subtypes in #cholangiocarcinoma: anatomy is only scratching the surface https://t.co/1gDNOkxuRG
RT @angelopirozzi3: Subtypes in #cholangiocarcinoma: anatomy is only scratching the surface https://t.co/1gDNOkxuRG
RT @angelopirozzi3: Subtypes in #cholangiocarcinoma: anatomy is only scratching the surface https://t.co/1gDNOkxuRG
RT @angelopirozzi3: Subtypes in #cholangiocarcinoma: anatomy is only scratching the surface https://t.co/1gDNOkxuRG
RT @angelopirozzi3: Subtypes in #cholangiocarcinoma: anatomy is only scratching the surface https://t.co/1gDNOkxuRG
RT @angelopirozzi3: Subtypes in #cholangiocarcinoma: anatomy is only scratching the surface https://t.co/1gDNOkxuRG
RT @angelopirozzi3: Subtypes in #cholangiocarcinoma: anatomy is only scratching the surface https://t.co/1gDNOkxuRG
RT @MarkYarchoan: Excited to share our manuscript w/ genomic & transcriptomic data from >450 #Cholangiocarcinoma pts in JCO PO: https://t.c…
Subtypes in #cholangiocarcinoma: anatomy is only scratching the surface https://t.co/1gDNOkxuRG
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine
Interesting paper on immune RNA-seq signatures in biliary tract cancers. Nice multi-institution collaboration led by Dr. Mody @MayoClinic and @MarkYarchoan @JohnsHopkins in collaboration with @TempusLabs https://t.co/91q4CEgat0
RT @MarkYarchoan: Excited to share our manuscript w/ genomic & transcriptomic data from >450 #Cholangiocarcinoma pts in JCO PO: https://t.c…
RT @mtmdphd: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8…
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsKNI7d #hpbcsm #PrecisionMedicine https://t.co/YoYVqbA5Ph
RT @MarkYarchoan: Excited to share our manuscript w/ genomic & transcriptomic data from >450 #Cholangiocarcinoma pts in JCO PO: https://t.c…
RT @MarkYarchoan: Excited to share our manuscript w/ genomic & transcriptomic data from >450 #Cholangiocarcinoma pts in JCO PO: https://t.c…
RT @MarkYarchoan: Excited to share our manuscript w/ genomic & transcriptomic data from >450 #Cholangiocarcinoma pts in JCO PO: https://t.c…
RT @OsamaRahma2: Immune and genomic profiling in BTC https://t.co/YHVhccWe9i
RT @MarkYarchoan: Excited to share our manuscript w/ genomic & transcriptomic data from >450 #Cholangiocarcinoma pts in JCO PO: https://t.c…
RT @MarkYarchoan: Excited to share our manuscript w/ genomic & transcriptomic data from >450 #Cholangiocarcinoma pts in JCO PO: https://t.c…
RT @LiteratureFeed: Mutational Signatures: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Spe…
RT @MarkYarchoan: Excited to share our manuscript w/ genomic & transcriptomic data from >450 #Cholangiocarcinoma pts in JCO PO: https://t.c…
RT @MarkYarchoan: Excited to share our manuscript w/ genomic & transcriptomic data from >450 #Cholangiocarcinoma pts in JCO PO: https://t.c…
Mutational Signatures: Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures https://t.co/Ap42rS1Yqm https://t.co/DYZN4UU2XM
RT @MarkYarchoan: Excited to share our manuscript w/ genomic & transcriptomic data from >450 #Cholangiocarcinoma pts in JCO PO: https://t.c…
RT @MarkYarchoan: Excited to share our manuscript w/ genomic & transcriptomic data from >450 #Cholangiocarcinoma pts in JCO PO: https://t.c…
RT @MarkYarchoan: Excited to share our manuscript w/ genomic & transcriptomic data from >450 #Cholangiocarcinoma pts in JCO PO: https://t.c…
RT @MarkYarchoan: Excited to share our manuscript w/ genomic & transcriptomic data from >450 #Cholangiocarcinoma pts in JCO PO: https://t.c…